Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

WAY vs CON: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

WAY Wins Head-to-Head Institutional Verdict (3–3 across 6 Pillars · 5–4 Matrix Metrics)

WAY Overall Winner 6-Pillar Tally: WAY 3 – 3 CON Matrix Metrics: WAY 5 – 4 CON

As of Nov 20, 2026, Waystar Holding Corp. (WAY) is the stronger overall head-to-head candidate over Concentra Group Holdings Parent, Inc. (CON) in the Tradestie Institutional Equity Comparison Engine, winning 5–4 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Profitability & Quality, Balance Sheet & Cash Flow, R&D & Supply-Chain Moat). WAY carries a Unified Composite Score of 24.9/100 (STRONG SELL) at $26.52 (14.1x Forward P/E, 23.1% operating margin), whereas CON carries 43.5/100 (HOLD) at $41.84 (22.0x Forward P/E, 17.2% operating margin).

  • Composite vs. Pillar Nuance: While CON currently prints a higher short-term Unified Composite Score (43.5/100 HOLD vs. WAY 24.9/100 STRONG SELL), WAY captures the overall institutional head-to-head verdict (5–4 matrix metrics and 3–3 across the 6 pillars) due to superior fundamental profitability (23.1% vs. 17.2% operating margin) and revenue trajectory (+21.2% vs. +8.6% YoY).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About WAY vs CON
WAY NASDAQ Head-to-Head Winner
Waystar Holding Corp. Common Stock
Services-Computer Integrated Systems Design
$26.52
-2.1% 1D
Market Cap $5.2B
TTM Revenue $1.26B
Forward P/E 14.1x
Beta / 30D Vol 0.39β · 38% Vol
Unified Composite Score
24.9 / 100 STRONG SELL
Tech 27.0 Fund 35.0 Flow 57.0 Mom 20.9
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 40
RSI-14: 40.0 · SMA20: $28.25 · SMA50: $27.15
CON NYSE
Concentra Group Holdings Parent, Inc.
Services-Specialty Outpatient Facilities, Nec
$41.84
+0.94% 1D
Market Cap $5.2B
TTM Revenue $2.34B
Forward P/E 22.0x
Beta / 30D Vol 0.52β · 38% Vol
Unified Composite Score
43.5 / 100 HOLD
Tech 31.0 Fund 47.0 Flow 69.0 Mom 41.1
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (8.0% over 20 days), RSI 56
RSI-14: 55.6 · SMA20: $41.80 · SMA50: $38.66

6-Pillar Scorecard Institutional Category Breakdown (WAY 3 – 3 CON)

Columns: Metric · WAY · CON
1. Valuation Multiples CON
Forward P/E 14.1x 22.0x
Trailing P/E 39.3x 24.5x
PEG Ratio N/M N/M
EV / Revenue 5.3x 3.1x
2. Growth & Scale CON
Revenue Growth (YoY) +21.2% +8.6%
Earnings Growth (YoY) -5.9% +36.4%
TTM Revenue (USD) $1.26B $2.34B
Market Cap $5.2B $5.2B
3. Profitability & Quality WAY
Gross Margin 69.4% 29.9%
Operating Margin 23.1% 17.2%
Net Profit Margin 10.7% 9.3%
Return on Equity (ROE) 3.7% 47.2%
4. Balance Sheet & Cash Flow WAY
Cash Generation (TTM) $264M $257M
Cash Flow Margin 20.9% 11.0%
Net Cash / Leverage $1.45B Net Debt (0.37x D/E) $2.04B Net Debt (4.20x D/E)
Dividend Yield None (0.00%) 0.60%
5. Options & Positioning CON
Options Structure Phase CONSOLIDATION BREAKOUT
Current IV / %ile 295.5% (100th %ile) 269.9% (95th %ile)
Put/Call OI Skew 0.22x (Call-Skewed) 0.79x (Call-Skewed)
OBV Trend / Tech Phase DISTRIBUTION · Neutral NEUTRAL · Markup
6. R&D & Supply-Chain Moat WAY
OpEx & R&D Intensity 46.3% of Rev ($585M) 12.7% of Rev ($297M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat High-Margin Pricing Power Moat
Supply-Chain Role Health Information Services Operator Medical Care Facilities Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: WAY (5) vs CON (4)
Institutional Metric WAY CON Criterion Row Edge
Market Capitalization
Scale
$5.2B $5.2B Larger Scale Tie
Trailing P/E Ratio
Valuation
39.3x 24.5x Lower Multiple CON
Forward P/E Ratio
Valuation
14.1x 22.0x Lower Multiple WAY
Revenue Growth (YoY)
Growth
+21.2% +8.6% Higher Growth WAY
Operating Margin (TTM)
Profitability
23.1% 17.2% Higher Margin WAY
Net Profit Margin
Profitability
10.7% 9.3% Higher Margin WAY
Return on Equity (ROE)
Capital Efficiency
3.7% 47.2% Higher ROE CON
52-Week Range Position
Momentum
46% ($17–$38) 91% ($19–$44) Stronger Trend CON
Beta / 30D Volatility
Risk Regime
0.39β · 38% Vol 0.52β · 38% Vol Lower Realized Risk WAY
Unified Institutional Score
Composite Signal
24.9 / 100 (STRONG SELL) 43.5 / 100 (HOLD) Higher Composite CON
Trailing 12M Revenue (USD)
Operating Scale
$1.26B $2.34B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
69.4% 29.9% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 5.3x EV/Rev N/M PEG · 3.1x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$264M ($1.45B Net Debt (0.37x D/E)) $257M ($2.04B Net Debt (4.20x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon CON +13.17 pp
WAY: -8.49% · CON: +4.68%
3M Horizon CON +14.96 pp
WAY: +4.62% · CON: +19.58%
6M Horizon CON +29.73 pp
WAY: +35.51% · CON: +65.24%
1Y Horizon CON +141.37 pp
WAY: -23.79% · CON: +117.58%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period WAY Revenue CON Revenue WAY Op. Margin CON Op. Margin Margin Leader
FY2022 $700M $1.72B 12.7% 15.0% CON
FY2023 $790M $1.84B 18.0% 15.6% WAY
FY2024 $940M $1.90B 13.1% 16.0% CON
FY2025 $1.10B $2.16B 22.7% 15.4% WAY

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
WAY CONSOLIDATION
48d in phase · OBV DISTRIBUTION
Current IV 295.5%
IV Percentile 100th %ile
Put/Call OI Skew 0.22x (Call-Skewed)
IV Regime Extreme (>80th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BEARISH
OBV Flow DISTRIBUTION
Exact WAY Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
CON BREAKOUT
99d in phase · OBV NEUTRAL
Current IV 269.9%
IV Percentile 95th %ile
Put/Call OI Skew 0.79x (Call-Skewed)
IV Regime Extreme (>80th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact CON Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
LIVE OPTIONS CHAIN · T+5 TRADING DAY HORIZON Spot $27.54 · IV 56.2%

WAY Simulated 5-Day Option Payoffs vs. Owning 100 Shares ($2,754)

Compare $2,754 in 100-share capital outlay against risk-defined 5-day vertical spreads, put-wall income, and 3-leg structures at 56.2% ATM IV.

5-DAY BULLISH SWING Liq C

Dec 18 $27.5 / $30 Bull Call Spread

Buy 1x $27.5C · Sell 1x $30C · 30d

Net Entry $134 Debit
T+5d @ +5% Move +$27 (+20%)
Max Risk / Buffer $134 Capped
5d Edge & Liquidity 0.7x R:R · Liq C
Simulate 5-Day Payoff →
ASYMMETRIC 3-LEG STRUCTURE Liq C

Dec 18 $25P / $27.5-$30C Seagull

Sell 1x $25P · Buy 1x $27.5/$30C · 30d

Net Entry $79 Debit
T+5d @ +5% Move +$58 (+13.4% RoM)
Max Risk / Buffer -9.2% Put Cushion ($431 Mgn)
5d Edge & Liquidity 0.7x R:R · Liq C
Simulate 5-Day Payoff →

Simulated T+5 trading day payoffs use live option midpoints, bid-ask spread adjustments, and implied volatility skew for educational scenario modeling only — not personalized investment advice. Options involve substantial risk.

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
WAY Moat Profile Scale & Operating Efficiency Moat
Health Information Services Operator
Competes within the Health Information Services value chain with $5.2B market capitalization and 23.1% operating margin.
OpEx & R&D Reinvestment 46.3% of Rev ($585M)
90D Engineering Disclosures 0 Published
CON Moat Profile High-Margin Pricing Power Moat
Medical Care Facilities Operator
Competes within the Medical Care Facilities value chain with $5.2B market capitalization and 17.2% operating margin.
OpEx & R&D Reinvestment 12.7% of Rev ($297M)
90D Engineering Disclosures 0 Published

Investor FAQ WAY vs CON Key Questions & Quantitative Answers

As of Nov 20, 2026, Waystar Holding Corp. (WAY) is the stronger overall head-to-head candidate over Concentra Group Holdings Parent, Inc. (CON) in the Tradestie Institutional Equity Comparison Engine, winning 5–4 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Profitability & Quality, Balance Sheet & Cash Flow, R&D & Supply-Chain Moat). WAY carries a Unified Composite Score of 24.9/100 (STRONG SELL) at $26.52 (14.1x Forward P/E, 23.1% operating margin), whereas CON carries 43.5/100 (HOLD) at $41.84 (22.0x Forward P/E, 17.2% operating margin). Composite vs. Pillar Nuance: While CON currently prints a higher short-term Unified Composite Score (43.5/100 HOLD vs. WAY 24.9/100 STRONG SELL), WAY captures the overall institutional head-to-head verdict (5–4 matrix metrics and 3–3 across the 6 pillars) due to superior fundamental profitability (23.1% vs. 17.2% operating margin) and revenue trajectory (+21.2% vs. +8.6% YoY).

CON leads the Growth & Scale pillar: WAY posts +21.2% YoY revenue growth and -5.9% YoY earnings growth on $1.26B TTM revenue (69.4% gross margin, 23.1% operating margin), compared with CON at +8.6% YoY revenue growth and +36.4% YoY earnings growth on $2.34B TTM revenue (29.9% gross margin, 17.2% operating margin). Across the 4-period historical trajectory (FY2022 to FY2025), WAY cumulative revenue shifted +57.1% while CON shifted +25.6%. In operating R&D and SG&A reinvestment, WAY deploys 46.3% of Rev ($585M) (0 90-day corporate R&D disclosures) versus 12.7% of Rev ($297M) (0 disclosures) for CON.

CON screens cheaper on headline valuation multiples. WAY trades at 14.1x Forward P/E, 39.3x Trailing P/E, N/M PEG, and 5.3x EV/Revenue (20.9% FCF margin), whereas CON trades at 22.0x Forward P/E, 24.5x Trailing P/E, N/M PEG, and 3.1x EV/Revenue (11.0% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against WAY (3.7% ROE) versus CON (47.2% ROE) capital efficiency.

In options market volatility and institutional positioning, WAY carries 295.5% implied volatility (100th %ile, Extreme (>80th %ile)), a 0.22x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (0.39β · 38% Vol realized risk). By comparison, CON carries 269.9% implied volatility (95th %ile, Extreme (>80th %ile)), a 0.79x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a BREAKOUT options structure phase (0.52β · 38% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.